Entocort EC
Links shared publicly online about this topic
Mylan Inc. - Mylan Launches First Generic Version of Entocort EC® Capsules
investor.mylan.com — “Mylan Inc. - Mylan Launches First Generic Version of Entocort EC® Capsules” View full resource at investor.mylan.com
Most Recently Shared on June 24, 2011 at 11:00 am By:
eyeonfda Pharma and Health Lawyer
Mylan Launches First Generic Version of Entocort EC® Capsules for #Crohn's - http://ow.ly/5pq2u
Teva agrees to settle patent litigation regarding generic version of AstraZeneca's Entocort EC capsules
news-medical.net — “Teva Pharmaceutical Industries Ltd. announced today that it has entered into an agreement with AstraZeneca to settle patent litigation regarding Teva's U.S. generic version of AstraZeneca's Entocort EC (budesonide) capsules.” View full resource at news-medical.net
Most Recently Shared on May 18, 2010 at 2:02 pm By:
Medicare News: Teva agrees to settle patent litigation regarding generic version of AstraZeneca's Entocort EC caps... http://bit.ly/d0KcXC
A Novel Oral Drug For The Treatment Of Moderate To Severe Crohn's Disease Would Earn 40 Percent Patient Share In The U.S. And Europe
medicalnewstoday.com — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that for the treatment of Crohn's disease, a novel oral drug for the trea” View full resource at medicalnewstoday.com
Most Recently Shared on April 15, 2010 at 3:14 pm By:
A Novel Oral Drug For The Treatment Of Moderate To Severe Crohn's Disease Would Earn 40 Percent Patient Share In The U... http://mnt.to/3BgD
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
-
News-Medical.Net
Stay up to date with the latest Medicare news via News-Medical.Net
-
MNT Crohn's / IBD
The latest crohn's disease and IBD news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
